Dear Colleagues
It is a real pleasure to announce the 3rd Christmas Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.
Cardiology and cardiovascular medicine in general, is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.
We have selected an international Faculty of high standing experts both from the Trust and worldwide, covering the entire spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.
We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy two days of interactive education for the benefit of your practice and your patients.
Yours sincerely,
Prof. Thomas F. Lüscher
MD, FRPC, FESC
Dr. Richard Grocott-Mason
MD, FRCP
Prof. Kim Fox
MD, FRCP, FESC
Dr. Bernard J. Gersh
FACC
Prof. Peter Libby
FACC
Dr. Ruth Amstein
FESC
In collaboration with
Under the Auspices of
Programme
Program Monday
Program Tuesday
Monday, December 16th, 2019
Venue: Royal Society of Medicine, London
| 08:30 - 08:45 | Welcome Address | ||
| 08:30 | The Royal Brompton & Harefield Hospital Trust | T.F. Lüscher, London/Zurich, K. Fox, London and R. Grocott-Mason, London |
| 08:40 | Learning objectives and assessment | R. Amstein, Zurich |
|
08:45 - 09:45 | Opening Lectures: Frontiers in Cardiovascular Science Chairs: K. Fox, London and R. Grocott-Mason, London |
||
| 08:45 |
Opening Lecture1: Artificial intelligence: What does it provide for medicine? |
P.A. Friedman, Rochester |
| 09:15 |
Opening Lecture 2: Environmental hazards and cardiovascular diesease: A call for action |
T. Münzel, Mainz |
| 09:45-10:15 | COFFEE BREAK | |
|
10:15 - 13:00 | Session 1: Risk Factors and Prevention Chairs: M.D. Lobo, London; R. Grocott-Mason, London and R.F. Storey, Sheffield |
||
| 10:15 | Hypertension: Drugs or devices? | F. Mahfoud, Homburg/Saar |
| 10:35 | Dyslipidaemias: How do the new ESC Guidelines affect my practice? | A.L. Catapano, Milan |
| 10:55 | Genetic tools to treat lipid disorders: PCSK9 inhibition and beyond | K. Ray, London |
| 11:15 | Lipoprotein (a), a new risk factor? | F. Mach, Geneva |
| 11:35 | Diabetes: New ESC Guidelines, new treatments | F. Cosentino, Stockholm |
| 11:55 | Cardiovascular risk management in diabetes | J. Deanfield, London |
| 12:15 | The microbiome as a new CV risk factor | T.F. Lüscher, London/Zurich |
| 12:35 | Panel discussion | all |
| 13:00-14:00 | LUNCH BUFFET | |
|
14:00 - 16:15 | Session 2: Acute and Chronic Coronary Syndromes Chairs: A. Baumbach, London and A. Magdy, Cairo |
||
| 14:00 | A reassessment of the mechanisms of the acute coronary syndromes | P. Libby, Boston |
| 14:20 | Chronic coronary syndromes: Revascularization strategies (new ESC Guidelines) | W. Wijns, Galway |
| 14:40 | Chronic coronary syndromes: Diagnostic aspects and noninvasive testing (new ESC Guidelines) | J.J. Bax, Leiden |
| 15:00 | A patient with chronic coronary syndromes: How to implement the new ESC Guidelines (interactive voting) | L. Räber, Berne |
| 15:20 | "INOCA" and "MINOCA": Prevalence, prognosis and diagnostic assessment | F. Crea, Rome |
| 15:40 | Long-term secondary prevention after MI: DAPT, DATT or antiplatelet monotherapy? | R.F. Storey, Sheffield |
| 16:00 | Panel discussion | all |
| 16:15-16:45 | COFFEE BREAK | |
|
16:45 - 18:30 | Session 3: Arrhythmias Chair: S. Haldar, London and T. Wong, London |
||
| 16:45 | Supraventricular tachycardias: How to implement the new ESC Guidelines into clinical practice | C. Blomstrom-Lundqvist, Uppsala |
| 17:05 | Pathophysiology and management of clinically silent AF | B.J. Gersh, Rochester |
| 17:25 | Atrial fibrillation: Medical therapy or ablation? | A.J. Camm, London |
| 17:45 | The Apple Heart Study: Will the smartwatch replace the doctor? | P. Kirchhof, Birmingham |
| 18:05 | Panel discussion | all |
| 18:30 | COCKTAIL RECEPTION | |
Tuesday, December 17th, 2019
Venue: Royal Society of Medicine, London
|
08:30 - 10:30 | Session 4: Valvular Heart Disease: Catheter-based or Open Surgery? Chairs: J.J. Bax, Leiden, M. Dalby, Harefield and M. Packer, Dallas |
||
|
08:30 08:45 09:00 |
Debate: Aortic stenosis: What is left for surgery? Very little Quite a lot Rebuttals |
S. Windecker, Berne M. Arsalan, Frankfurt |
| 09:10 | Mitral regurgitation: Mitraclip vs. surgery | B. Prendergast, London |
| 09:30 | A challenging patient with mitral regurgitation (interactive voting) | R. Smith, London |
| 09:50 | Tricuspid regurgitation: The new frontier | F. Maisano, Zurich |
| 10:10 | Panel discussion | all |
| 10:30-11:00 | COFFEE BREAK | |
|
11:00 - 12:30 | Session 5: Chronic Heart Failure Chairs: M. Metra, Brescia and F. Mach, Geneva |
||
| 11:00 | Management of HFrEF: From diuretics to ARNI and beyond | M. Packer, Dallas |
| 11:20 | Evidence-based therapies in HFpEF | M. Cowie, London |
| 11:40 | New drugs for diabetes and HF | S. Anker, Berlin |
| 12:00 | Which patients benefit from CRT? | J. Cleland, Glasgow |
| 12:20 | Panel discussion | all |
|
12:30 - 13:00 | Frontieres in Renal Nerve Ablation Sponsored by Ablative Solutions Chairs: B. Gersh, Rochester and T.F. Lüscher, London/Zurich |
||
| 12:30 | Renal nerve ablation: Current evidence and future perspectives | M. Lobo, London |
| 12:40 | Alcohol ablation of renal nerves: A new concept of hypertension management? | F. Mahfoud, Homburg/Saar |
| 12:50 | Panel discussion | all |
| 13:00-13:45 | LUNCH BUFFET | |
|
13:45 - 15:15 | Session 6: Acute and Advanced Heart Failure Chairs: M. G. Crespo Leiro, La Coruña and J. Cleland, Glasgow |
||
| 13:45 | Optimal medical treatment for acute and advanced HF | M. Metra, Brescia |
| 14:05 | Mechanical circulatory support: Indications and outcome | M.R. Mehra, Boston |
| 14:25 | Heart transplantation: for whom? | M.G. Crespo Leiro, La Coruña |
| 14:45 | Palliation and advanced care planning in HF | M. Johnson, Hull |
| 15:05 | Panel discussion | all |
| 15:15-15:30 | COFFEE BREAK | |
|
15:30 - 16:30 | Session 7: Cardio-oncology Chairs: B.J. Gersh, Rochester and M. Mehra, Boston |
||
| 15:30 | Cancer and cardiovascular disease | T. Suter, Berne |
| 15:50 | Cardiotoxicity of chemotherapy: Which drugs matter? | A. Lyon, London |
| 16:10 | Amyloidosis: Novel treatment options | P.N. Hawkins, London |
|
16:30 - 17:00 | The Paul Hamilton Wood Lecture Chairs: K. Fox and T.F. Lüscher, London/Zurich |
||
| 16:30 | UK Biobank: A powerful tool to gain novel insights into cardiovascular disease | R. Collins, Oxford |
| 17:00 | Wrap-up and Close | T.F. Lüscher, London/Zurich |
Contributors
Stefan D. Anker
Berlin, DE
Mani Arsalan
Frankfurt, DE
Andreas Baumbach
Bristol, GB
Jeroen J. Bax
Leiden, NL
Carina Blomstrom-Lundqvist
Uppsala, SE
A. John Camm
London, GB
Alberico L. Catapano
Milan, IT
John Cleland
Glasgow, GB
Sir Rory Collins
Oxford, GB
Francesco Cosentino
Stockholm, SE
Martin Cowie
London, GB
Filippo Crea
Rome, IT
Marisa G. Crespo Leiro
La Coruña, ES
Miles Dalby
Harefield, GB
John E. Deanfield
London, GB
Kim Fox
London, GB
Paul A. Friedman
Rochester, US
Bernard J. Gersh
Rochester MN, US
Richard Grocott-Mason
London, GB
Shouvik Haldar
London, GB
Philip N. Hawkins
London, GB
Miriam Johnson
Hull, GB
Paulus Kirchhof
Birmingham, GB
Peter Libby
Boston, US
Melvin D. Lobo
London, GB
Thomas F. Lüscher
London, GB/Zurich, CH
Alexander Lyon
London, GB
François Mach
Geneva, CH
Ahmed Magdy
Cairo, EG
Felix Mahfoud
Homburg/Saar, DE
Francesco Maisano
Zurich, CH
Mandeep R. Mehra
Boston, US
Marco Metra
Brescia, IT
Thomas Münzel
Mainz, DE
Milton Packer
Dallas, US
Bernard Prendergast
London, GB
Lorenz Räber
Berne, CH
Kausik Ray
London, GB
Robert Smith
London, GB
Robert F. Storey
Sheffield, GB
Thomas Suter
Berne, CH
William Wijns
Galway, IE
Stephan Windecker
Berne, CH
Tom Wong
Chelsea, London, GB
Sir Magdy Yacoub
London, GB
General Information
Registration
| Category | Price |
|---|---|
| Registration fees | |
| Regular fee | GBP 300 |
| Early registration fee (before November 16, 2019) | GBP 250 |
| ESC / Association Members | |
| Regular fee | GBP 280 |
| Early registration fee (before November 16, 2019) | GBP 230 |
| Trainees/Residents, Research fellows, Nurses, Students <35 years (ID proof required) | |
| Regular fee | GBP 150 |
| Early registration fee (before November 16, 2019) | GBP 100 |
| Day ticket | GBP 150 |
For group registrations a minimum number of 10 participants is required. Please contact Nadine-Estelle Kaltheuner to obtain further information.
Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.
Registration Deadline
Online registration closed December 11, 2019. You may register at the venue on the day of the event. Please note: Payment in cash ONLY, in the exact amount.
Modification & Cancellation
All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancellation up to 18 November 2019, deposits will be refunded less GBP 50 for administrative costs. After this date, no refund will be possible.
Organisation
Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Nadine-Estelle Kaltheuner
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90
Venue
The Royal Society of Medicine
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom
Accreditation
The Cardiology Update London has been approved by:
Federation of the Royal Colleges of Physicians of the United Kingdom for CPD credits
12 category 1 (external) CPD credits
EACCME-UEMS
European Accreditation Council for Continuing Medical Education (AECCME®)
with 11 European CME credits (ECMEC®s)
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
British Cardiovascular Society
Platinum Sponsor(s)
Gold Sponsor(s)
Silver Sponsor(s)
Co-Sponsors
